I posted a lenghty description of Lucanix, an experimental new treatment for advanced NSCLC, further down the board in the "New Treatments/Clinical Trials" section. I would encourage anyone readbing this who has been confirmed with either stage III-A, stage III-B or stage IV NSCLC and who has exhibited an initial positive response (defined by either measurable tumor reduction or disease stabilization) to first-line treatment with a platinum-based chemotherapy agent such as carboplatin to review my notes as well as this link:

http://www.clinicaltrials.gov/ct2/show/ ... ocs=Y#locn

If you can qualify, it may be something you'd want to consider.